Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Desacetyl-Diltiazem Displays Severalfold Higher Affinity to CYP2D6 Compared with CYP3A4

Espen Molden, Anders Åsberg and Hege Christensen
Drug Metabolism and Disposition January 2002, 30 (1) 1-3; DOI: https://doi.org/10.1124/dmd.30.1.1
Espen Molden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anders Åsberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hege Christensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 30 no. 1 1-3
DOI 
https://doi.org/10.1124/dmd.30.1.1
PubMed 
11744603

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 13, 2001
  • Accepted September 20, 2001
  • Published online January 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Espen Molden1,
  2. Anders Åsberg2 and
  3. Hege Christensen1
  1. 1Department of Pharmacology, School of Pharmacy, University of Oslo, Oslo, Norway (E.M., H.C.); 2Laboratory for Renal Physiology, Section of Nephrology, Medical Department, National Hospital, University of Oslo, Oslo, Norway (A. Å.)
  1. Espen Molden, Department of Pharmacology, School of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, N-0316 Oslo, Norway. E-mail: espen.molden{at}farmasi.uio.no
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to August 2022

AbstractFullPdf
Aug 201701410
Sep 201711710
Oct 20171179
Nov 20170554
Dec 201701937
Jan 201831682
Feb 20183935
Mar 20180612
Apr 20180313
May 20181367
Jun 20180364
Jul 20180221
Aug 2018081
Sep 20181187
Oct 20180276
Nov 20181207
Dec 20181851
Jan 20194211
Feb 20191810
Mar 20192010
Apr 20191800
May 20191310
Jun 2019813
Jul 2019600
Aug 2019900
Oct 20191310
Nov 20191521
Dec 20192000
Jan 20201310
Feb 20202000
Mar 2020921
May 20201900
Jun 20201521
Jul 20201300
Aug 2020213
Sep 2020420
Oct 20201900
Nov 2020500
Dec 20201911
Jan 20211341
Feb 20211442
Mar 20211621
Apr 2021321
May 20211043
Jun 20211310
Jul 2021920
Aug 20211321
Sep 2021410
Oct 2021895
Nov 20211632
Dec 20211611
Jan 20222230
Feb 20221710
Mar 20221820
Apr 2022921
May 2022730
Jun 20223011
Jul 20221810
Aug 2022900

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (1)
Drug Metabolism and Disposition
Vol. 30, Issue 1
1 Jan 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Desacetyl-Diltiazem Displays Severalfold Higher Affinity to CYP2D6 Compared with CYP3A4
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

Desacetyl-Diltiazem Displays Severalfold Higher Affinity to CYP2D6 Compared with CYP3A4

Espen Molden, Anders Åsberg and Hege Christensen
Drug Metabolism and Disposition January 1, 2002, 30 (1) 1-3; DOI: https://doi.org/10.1124/dmd.30.1.1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid CommunicationShort Communication

Desacetyl-Diltiazem Displays Severalfold Higher Affinity to CYP2D6 Compared with CYP3A4

Espen Molden, Anders Åsberg and Hege Christensen
Drug Metabolism and Disposition January 1, 2002, 30 (1) 1-3; DOI: https://doi.org/10.1124/dmd.30.1.1
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communication

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics